Terumo Medical Corp.: FDA filings under this applicant name
FDA lists 157 510(k) clearances under 2 spellings of the applicant name “Terumo Medical Corp.” (first 1980, latest 2023), plus 3 PMA decisions, across 60 product codes in 11 review panels. Median 510(k) review time under this name: 64 days. Since 2017 the median was 85 days, against 148 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Terumo, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 1 | 76 |
| 2013 | 1 | 189 |
| 2014 | 1 | 105 |
| 2015 | 3 | 108 |
| 2016 | 0 | — |
| 2017 | 2 | 96 |
| 2018 | 2 | 113 |
| 2019 | 0 | — |
| 2020 | 1 | 55 |
| 2021 | 1 | 45 |
| 2022 | 0 | — |
| 2023 | 1 | 106 |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Terumo Medical Corp. took a median 85 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 148 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DYB | Introducer, Catheter | 27 | 27 |
| DQX | Wire, Guide, Catheter | 11 | 11 |
| DTZ | Oxygenator, Cardiopulmonary Bypass | 10 | 10 |
| FMF | Syringe, Piston | 10 | 10 |
| DQO | Catheter, Intravascular, Diagnostic | 6 | 6 |
| FJI | Dialyzer, Capillary, Hollow Fiber | 6 | 6 |
| FPA | Set, Administration, Intravascular | 6 | 6 |
| FOZ | Catheter, Intravascular, Therapeutic, Short-Term Less Than 30 Days | 5 | 5 |
| DQY | Catheter, Percutaneous | 4 | 4 |
| DTN | Reservoir, Blood, Cardiopulmonary Bypass | 4 | 4 |
Plus 50 more product codes.
Review panels
- Cardiovascular (80)
- General Hospital (34)
- Gastroenterology and Urology (19)
- Clinical Chemistry (16)
- Anesthesiology (4)
- General and Plastic Surgery (2)
- Dental (1)
- Immunology (1)
- Obstetrics and Gynecology (1)
- Ophthalmic (1)
- Clinical Toxicology (1)
Most recent Terumo Medical Corp. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K231044 | R2P Navicross | DQY | 2023-07-27 | 106 |
| K213531 | TR BAND Radial Compression Device | DXC | 2021-12-20 | 45 |
| K193125 | R2P Destination Slender Guiding Sheath | DYB | 2020-01-06 | 55 |
| K181237 | Glidesheath Slender Tibial Pedal Kit | DYB | 2018-08-03 | 85 |
| K173831 | Glidesheath Slender | DYB | 2018-05-08 | 141 |
| K172995 | Destination Carotid Guiding Sheath, Destination Peripheral Guiding Sheath, Destination Renal Guiding Sheath | DYB | 2017-11-21 | 55 |
| K171491 | R2P Destination Slender Guiding Sheath | DYB | 2017-10-05 | 136 |
| K152173 | Glidesheath | DYB | 2015-12-01 | 119 |
| K152525 | TR BAND Radial Compression Device | DXC | 2015-11-10 | 68 |
| K151471 | Radifocus Glidewire Endoscopic Wire | OCY | 2015-09-17 | 108 |
147 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P210017 | PMA | Cross-Seal Suture-Mediated Vascular Closure Device System | 2023-09-26 |
| P140002 | PMA | MISAGO PERIPHERAL SELF-EXPANDING STENT SYSTEM | 2015-05-22 |
| P930038 | PMA | Angio Seal Vascular Closure Device | 1996-09-30 |
Recalls
44 product recalls in 15 recall events; 1 initiated in the last five years. Most recent: 2026-06-15.
7 product recalls in 6 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Asahi Medical Co Ltd (2), St. Jude Medical / Daig Division (2), Baxter Corporation Englewood (1).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Terumo Medical Corp. is the lead sponsor of 7 device studies on ClinicalTrials.gov (0 active or recruiting). Most recent:
- NCT05873452: Kaitoh Atherectomy FIH (Completed, started 2023-08-07)
- NCT02793492: Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery (Completed, started 2022-08-30)
- NCT04371861: Observational Study to Assess Transradial Access for Treatment in the Lower Extremities. (Completed, started 2020-06-29)
- NCT04272216: An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres (Completed, started 2020-02-06)
- NCT03756558: Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System (Completed, started 2019-08-09)
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Terumo Medical Corp. (a text match, not an official crosswalk):
- A4220 — Refill kit for implantable infusion pump (via FRN)
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter) (via FRN)
- E0785 — Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement (via FRN)
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Terumo Medical Corp. (143)
- Terumo Medical Corporation (17)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Terumo Cardiovascular Systems Corp. (74 510(k)s)
- Terumo Corp. (34 510(k)s)
- Terumo America, Inc. (31 510(k)s)
- Terumo Europe N.V. (28 510(k)s)
- Terumo Medical Products (Hangzhou) Co., Ltd. (5 510(k)s)
- Terumo (Philippines) Corporation (5 510(k)s)
- Terumo Clinical Supply Co., Ltd. (2 510(k)s)
- Terumo Bct (1 510(k)s)
- Terumo Cardiovascular Systems Thi Plant (1 510(k)s)
- Terumo Medical Coporation (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Terumo Medical Corp.?
FDA lists 157 510(k) clearances under 2 spellings of the applicant name “Terumo Medical Corp.” (first 1980, latest 2023), plus 3 PMA decisions, across 60 product codes in 11 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Terumo Medical Corp.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Terumo Medical Corp. is 64 days. Since 2017: 85 days, versus 148 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Terumo Medical Corp.?
The most frequent FDA product codes under this applicant name are DYB (Introducer, Catheter, 27); DQX (Wire, Guide, Catheter, 11); DTZ (Oxygenator, Cardiopulmonary Bypass, 10).
Next steps
- See all 157 Terumo Medical Corp. clearances with predicates and recalls
- Run predicate analysis for product code DYB, Terumo Medical Corp.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.